Article Details
Retrieved on: 2025-09-26 17:07:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The appointment strengthens CASI's leadership as it focuses on developing CID-103, its anti-CD38 monoclonal antibody ... monoclonal antibodies, and for ...
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here